evm14
Selected Types of Solid Tumor
Everest Medicines (Beijing) Co., Ltd.Phase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the Selected Types of Solid Tumor cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Everest Medicines (Beijing) Co., Ltd. | Phase 1/2 | CC |
Epirubicin Everest Medicines (Beijing) Co., Ltd. | Phase 1/2 | CC |
Pembrolizumab Everest Medicines (Beijing) Co., Ltd. | Phase 1/2 | CC |
Same molecule, other indications
evm14 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →